Page 9 - Mark Swallow News Today

/PRNewswire/ -- Quell Therapeutics Ltd ("Quell"), the world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions...

/PRNewswire/ -- Coave Therapeutics (Coave), a clinical-stage biotechnology company focused on developing life-changing gene therapies in rare Ocular and CNS...

/PRNewswire/ -- Coave Therapeutics (Coave), a clinical-stage biotechnology company focused on developing life-changing gene therapies in rare Ocular and CNS...

(0) - Coave Therapeutics is the new name for Horama and reflects its new emphasis on AAV-Ligand Conjugate based vectors for CNS diseases alongside Ocular diseases - Funding led by Seroba Life Sciences and supported by Théa Open Innovation, eureKARE and existing shareholders PARIS, July 21, 2021 /PRNewswire/ -- Coave Therapeutics (pronounced cove; formerly Horama), a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous...

Enterome to Present at Upcoming Conferences News provided by Share this article PARIS, April 7, 2021 /PRNewswire/ -- ENTEROME SA, a clinical stage biopharmaceutical company developing novel drugs based on its unique ability to de-code molecular interactions in the gut microbiome impacting human health, today announces that Pierre Bélichard, CEO, will present an overview of the Company and take part in 1-on-1 meetings with institutional investors at the following conferences: European Biotec...

Wedding and Diwali celebrations which allegedly breached Covid regulations could cost a Wolverhampton pub its licence.

Nouscom appoints Göran Ando MD as Chairman and Richard Davis PhD as Chief Business Officer News provided by Share this article Share this article BASEL, Switzerland, Dec. 11, 2020 /PRNewswire/ -- Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized genetic cancer vaccines, today announces that it has appointed Göran Ando, MD as the new Chairman of its Board of Directors. Nouscom also appointed Richard Davis, PhD as Chief Business Officer (CBO). Dr. Guid...